Skip to main content

Table 8 Tukey’s HSD test results for HNL levels

From: The immunosuppressive role of neutrophils in infectious and oncological conditions: A study of chemokine receptor CXCR3 and human neutrophil lipocalin levels

Group1

Group2

meandiff

p-adj

lower

upper

reject

Acute Resp. Infection

COVID-19 Recovered

20.000

0.001

11.128

28.872

True

Acute Resp. Infection

Oncology Patients

-10.000

0.091

-18.872

1.128

False

Acute Resp. Infection

Control Group

-20.000

0.004

-28.872

-11.128

True

Acute Resp. Infection

Prostate Cancer

-30.000

0.001

-38.872

-21.128

True

Acute Resp. Infection

Breast Cancer

-5.000

0.044

-13.872

3.872

True

Acute Resp. Infection

Colorectal Cancer

-10.000

0.091

-18.872

1.128

False

COVID-19 Recovered

Oncology Patients

-30.000

0.001

-38.872

-21.128

True

COVID-19 Recovered

Control Group

-40.000

0.000

-48.872

-31.128

True

COVID-19 Recovered

Prostate Cancer

-50.000

0.000

-58.872

-41.128

True

COVID-19 Recovered

Breast Cancer

-25.000

0.001

-33.872

-16.128

True

COVID-19 Recovered

Colorectal Cancer

-30.000

0.001

-38.872

-21.128

True

Oncology Patients

Control Group

-10.000

0.091

-18.872

1.128

False

Oncology Patients

Prostate Cancer

-20.000

0.001

-28.872

-11.128

True

Oncology Patients

Breast Cancer

-5.000

0.044

-13.872

3.872

True

Oncology Patients

Colorectal Cancer

0.000

0.900

-8.872

8.872

False

Control Group

Prostate Cancer

-10.000

0.091

-18.872

1.128

False

Control Group

Breast Cancer

-25.000

0.001

-33.872

-16.128

True

Control Group

Colorectal Cancer

-20.000

0.004

-28.872

-11.128

True

Prostate Cancer

Breast Cancer

-35.000

0.000

-43.872

-26.128

True

Prostate Cancer

Colorectal Cancer

-30.000

0.001

-38.872

-21.128

True

Breast Cancer

Colorectal Cancer

-5.000

0.091

-13.872

3.872

False